Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,446 total articles

Lexicon Pharmaceuticals Completes Enrollment of Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Non-Obstructive and Obstructive Hypertrophic Cardiomyopathy (HCM)

Lexicon Pharmaceuticals Completes Enrollment of Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Non-Obstructive and Obstructive Hypertrophic Cardiomyopathy (HCM)

Lexicon Pharmaceuticals announced the completion of patient enrollment for its Phase 3 SONATA-HCM trial evaluating sotagliflozin in patients with symptomatic non-obstructive and obstructive hypertrophic cardiomyopathy (HCM). The study exceeded its original target, enrolling over 500 patients across more than 130 sites in 20 countries. Topline resul…

SciSparc Announces Decision to Target the Agentic AI Market; Forms Scientific Advisory Board for Artificial Intelligence and Cybersecurity

SciSparc Announces Decision to Target the Agentic AI Market; Forms Scientific Advisory Board for Artificial Intelligence and Cybersecurity

SciSparc Ltd. announced plans to target the emerging agentic AI market by forming a Scientific Advisory Board focused on AI and cybersecurity. The company is evaluating opportunities and engaging with multiple firms in the agentic AI space, signaling a strategic expansion beyond its current pharmaceutical and cannabinoid product development operati…

Medicus Pharma Receives FDA “Study May Proceed” Letter for NDA-Enabling Registrational SkinJect® Study in Patients with Gorlin Syndrome

Medicus Pharma Receives FDA “Study May Proceed” Letter for NDA-Enabling Registrational SkinJect® Study in Patients with Gorlin Syndrome

Medicus Pharma received FDA clearance to initiate a pivotal Phase 2b clinical trial studying SkinJect®, a localized microneedle-based chemotherapy patch, in patients with Gorlin Syndrome who develop multiple basal cell carcinomas. This milestone advances the regulatory path towards a potential NDA submission targeting a rare disease with high unmet…

Turbo Energy Reports Record Preliminary First Half 2026 Results with 180% Revenue Growth and Positive Operating Income

Turbo Energy Reports Record Preliminary First Half 2026 Results with 180% Revenue Growth and Positive Operating Income

Turbo Energy, S.A., a Nasdaq-listed global technology integrator in AI-driven Intelligent Energy Storage and energy management solutions, announced preliminary unaudited financial results for H1 2026. The company reported a record 180% year-over-year revenue growth to $17.2 million, positive EBITDA and operating income, and net income turning posit…

AiRWA Inc. Announces Acquisition of Best Life, an Expanding Import-Export Company, to Complement Its AI Data Training Business

AiRWA Inc. Announces Acquisition of Best Life, an Expanding Import-Export Company, to Complement Its AI Data Training Business

AiRWA Inc. (Nasdaq: YYAI) announced a definitive agreement to acquire a 97% interest in Hongkong Best Life Trade Co., an import-export company with a customer base including Alibaba Health Hong Kong and Tmall. The acquisition, structured with performance-based earn-out payments, aims to diversify AiRWA's revenue streams beyond AI licensing and soci…

Veru Announces Full Enrollment for Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss

Veru Announces Full Enrollment for Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss

Veru Inc. announced full enrollment of 200 patients in its Phase 2b PLATEAU clinical trial evaluating the combination of enobosarm and semaglutide for improved and selective weight loss in older patients with obesity. Interim results are expected in Q1 2027, with final data by Q4 2027. The trial aims to demonstrate enhanced fat loss while preservin…

Bond CEO to Host Investor Webinar Announcing a Major Milestone in the Evolution of AI-Powered Preventative Personal Security

Bond CEO to Host Investor Webinar Announcing a Major Milestone in the Evolution of AI-Powered Preventative Personal Security

Our Bond, Inc., a New York-based company specializing in AI-enabled Preventative Personal Security, announced a live investor webinar hosted by CEO Doron Kempel to reveal new validation that could transform enterprise approaches to employee safety, risk management, and ROI. The company, operating in 28 countries and trusted by major corporations an…

Inseego Subscribe Achieves New CMMC Certification, Enabling Service Providers to Support U.S. Government Customers

Inseego Subscribe Achieves New CMMC Certification, Enabling Service Providers to Support U.S. Government Customers

Inseego Corp.'s subscriber lifecycle management platform, Inseego Subscribe, has achieved Cybersecurity Maturity Model Certification (CMMC) Level 2, enabling the platform to better support U.S. communication service providers serving federal government clients. This certification reinforces the platform's capability to meet stringent cybersecurity …

Linkage Global Unveils "Human Resonance OS," Advancing Its AI-Enabled Wellness Ecosystem as Next-Generation Healthcare Infrastructure

Linkage Global Unveils "Human Resonance OS," Advancing Its AI-Enabled Wellness Ecosystem as Next-Generation Healthcare Infrastructure

Linkage Global Inc. announced a strategic shift from hardware to an AI-enabled wellness ecosystem with its new Human Resonance OS, integrating neural audio technology and proprietary wellness audio copyrights. The company aims to position itself as a leader in preventative health, sleep technology, and corporate wellness by leveraging smart wearabl…

Kyverna Therapeutics and ElevateBio Enter into Commercial Manufacturing and Supply Agreement for Miv-cel

Kyverna Therapeutics and ElevateBio Enter into Commercial Manufacturing and Supply Agreement for Miv-cel

Kyverna Therapeutics has entered into a commercial manufacturing and supply agreement with ElevateBio to support the U.S. and global supply of its CAR T-cell therapy miv-cel. This agreement strengthens Kyverna's readiness for potential commercial launch in stiff person syndrome and other autoimmune indications, with a rolling FDA Biologics License …

Kaltura Delivers Record-Scale Live Streaming for the 2026 FIFA World Cup, Previews Agentic Avatar Experiences for Live Sports

Kaltura Delivers Record-Scale Live Streaming for the 2026 FIFA World Cup, Previews Agentic Avatar Experiences for Live Sports

Kaltura successfully delivered live TV streaming for the 2026 FIFA World Cup, handling a record demand with 1.3 billion playback sessions and 7 million concurrent viewers across six production environments globally. The company revamped its platform to a microservices architecture for better scalability and deployed AI agents to optimize live event…

Enphase Energy Publishes White Paper on Kestrel ASIC, Its Fifth-Generation Silicon Platform for Intelligent Power Conversion

Enphase Energy Publishes White Paper on Kestrel ASIC, Its Fifth-Generation Silicon Platform for Intelligent Power Conversion

Enphase Energy has published a white paper detailing its fifth-generation Kestrel application-specific integrated circuit (ASIC) designed to enhance intelligent power conversion in multiple product lines including microinverters, IQ Battery systems, EV chargers, and solid-state transformers. The Kestrel ASIC integrates advanced power control, secur…

Lightbridge Corporation and Quadrant Nuclear Industries Announce Memorandum of Understanding to Advance Domestic HALEU Fuel Supply

Lightbridge Corporation and Quadrant Nuclear Industries Announce Memorandum of Understanding to Advance Domestic HALEU Fuel Supply

Lightbridge Corporation (Nasdaq: LTBR) and Quadrant Nuclear Industries Inc. (QNI) have signed a non-binding memorandum of understanding to collaborate on establishing a domestic supply chain for high-assay low-enriched uranium (HALEU) fuel, essential for advanced nuclear reactors. This partnership aims to support Lightbridge's commercialization of …

Pacira BioSciences Advances PCRX-201 Development Program with Successful Transition to Scalable Commercial Manufacturing Process

Pacira BioSciences Advances PCRX-201 Development Program with Successful Transition to Scalable Commercial Manufacturing Process

Pacira BioSciences has transitioned its investigational gene therapy, PCRX-201, for knee osteoarthritis to a scalable U.S.-based commercial manufacturing process. This enabled enrollment of the first patient in Part B of the Phase 2 ASCEND study, with topline Part A data expected by end of 2026. The transition supports the company's growth strategy…

Genius Group Offers Share Loyalty Bonus Program Delivering up to 59% Return on Investment in six months, Closing July 31, 2026.

Genius Group Offers Share Loyalty Bonus Program Delivering up to 59% Return on Investment in six months, Closing July 31, 2026.

Genius Group Limited (NYSE American: GNS) announced the second round of its Share Loyalty Bonus Program, paying shareholders a $0.10 per share cash bonus after a six-month holding period. With the company's current share price at $0.17, this bonus represents a 59% return on investment and rewards long-term shareholders who hold their shares in book…

FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.

FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.

Freenome's SimpleScreen CRC blood-based colorectal cancer screening test received FDA approval for adults 45 and older at average risk. Abbott will commercialize the test in the U.S., leveraging its existing colorectal cancer screening infrastructure. The approval supports broader access, including Medicare coverage and American Cancer Society endo…

Waterco Modernizes B2B Ordering with BigCommerce, Improving Ordering and Buying Efficiency Across 45,000 Products

Waterco Modernizes B2B Ordering with BigCommerce, Improving Ordering and Buying Efficiency Across 45,000 Products

Commerce (Nasdaq: CMRC) announced that Waterco, a global swimming pool products manufacturer and distributor, has launched a new B2B buying experience using BigCommerce platform. By shifting from manual phone and email orders to a self-service digital platform handling over 45,000 products, Waterco aims to improve operational efficiency, support sc…